GH - Guardant Health, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$132.93
DETAILS
HIGH:
$175.00
LOW:
$110.00
MEDIAN:
$130.00
CONSENSUS:
$132.93
UPSIDE:
11.75%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||
| Revenue | 982.0 | 739.0 | 563.9 | 449.5 | 373.7 | 286.7 | 214.4 | 90.6 | 49.8 | 25.2 |
| Cost of Revenue | 349.0 | 289.8 | 227.1 | 156.3 | 122.9 | 92.5 | 70.7 | 43.2 | 31.6 | 22.1 |
| Gross Profit | 633.0 | 449.2 | 336.9 | 293.2 | 250.7 | 194.2 | 143.7 | 47.4 | 18.2 | 3.1 |
| Operating Expenses | ||||||||||
| R&D Expenses | 364.2 | 347.8 | 367.2 | 373.8 | 263.2 | 149.9 | 86.3 | 50.7 | 25.6 | 10.9 |
| SG&A Expenses | 706.1 | 545.1 | 451.0 | 463.8 | 398.5 | 299.3 | 139.7 | 89.7 | 69.3 | 36.1 |
| Other Expenses | 0 | 0 | 83.4 | 0 | 0 | 0 | 0.1 | 0 | 0 | (0.0) |
| Operating Expenses | 1,070.3 | 892.8 | 901.6 | 837.6 | 661.7 | 449.1 | 226.0 | 140.4 | 94.8 | 47.0 |
| Operating Income | ||||||||||
| Operating Income | (436.3) | (443.6) | (564.7) | (544.4) | (411.0) | (254.9) | (82.4) | (92.9) | (76.6) | (43.8) |
| Interest Expense | 3.9 | 2.6 | 2.6 | 2.6 | 2.6 | 4.8 | 1.2 | 1.3 | 2.7 | 3.0 |
| Interest Income | 34.1 | 53.7 | 35.4 | 6.1 | 3.9 | 10.2 | 13.7 | 5.3 | 2.2 | 0.7 |
| Profitability | ||||||||||
| EBITDA | (373.9) | (390.1) | (433.3) | (614.9) | (359.6) | (225.1) | (54.9) | (75.8) | (75.3) | (39.4) |
| EBIT | (413.6) | (432.5) | (476.2) | (650.9) | (381.9) | (241.1) | (68.5) | (83.0) | (80.5) | (43.1) |
| Income Before Tax | (417.5) | (435.1) | (478.8) | (653.4) | (384.5) | (245.9) | (69.7) | (84.2) | (83.2) | (46.1) |
| Income Tax Expense | (1.3) | 1.3 | 0.7 | 1.1 | 0.3 | 0.4 | (1.9) | 0.0 | 0.0 | 0.0 |
| Net Income | (416.3) | (436.4) | (479.4) | (654.6) | (405.7) | (253.8) | (75.7) | (85.1) | (83.2) | (46.1) |
| Per Share Data | ||||||||||
| EPS (Basic) | -3.32 | -3.56 | -4.28 | -6.41 | -3.80 | -2.53 | -0.75 | -1.00 | -1.18 | -3.49 |
| EPS (Diluted) | -3.32 | -3.56 | -4.28 | -6.41 | -3.80 | -2.53 | -0.75 | -1.00 | -1.18 | -3.49 |
| Shares Outstanding | 125.4 | 122.7 | 112.0 | 102.2 | 101.3 | 97.5 | 90.6 | 85.0 | 70.7 | 13.2 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||
| Cash & Cash Equivalents | 378.2 | 525.5 | 1,133.5 | 141.6 | 492.2 | 833.0 | 143.2 | 140.5 | 72.3 | 33.6 |
| Short-Term Investments | 823.4 | 314.4 | 35.1 | 869.6 | 440.5 | 961.9 | 379.6 | 278.4 | 149.0 | 61.7 |
| Net Receivables | 137.8 | 110.3 | 88.8 | 97.3 | 97.7 | 53.3 | 48.0 | 35.7 | 12.8 | 3.5 |
| Inventory | 85.9 | 71.1 | 61.9 | 51.6 | 30.7 | 22.7 | 15.2 | 9.1 | 7.3 | 2.8 |
| Other Current Assets | 40.7 | 33.8 | 27.7 | 31.5 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | 1,466.0 | 1,055.1 | 1,347.1 | 1,191.6 | 1,114.1 | 1,888.4 | 597.4 | 469.0 | 242.9 | 103.1 |
| Non-Current Assets | ||||||||||
| Property, Plant & Equipment | 304.8 | 279.1 | 302.7 | 341.9 | 313.9 | 100.1 | 72.8 | 31.0 | 16.0 | 12.6 |
| Goodwill | 77.3 | 3.3 | 3.3 | 3.3 | 3.3 | 3.3 | 3.3 | 0 | 0 | 0 |
| Intangible Assets | 25.9 | 6.8 | 9.0 | 11.7 | 14.2 | 16.2 | 15.4 | 7.8 | 8.7 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 698.0 | 246.6 | 268.8 | 77.6 | 73.3 | 0 |
| Other Non-Current Assets | 139.7 | 141.4 | 124.3 | 61.5 | 60.9 | 17.3 | 4.9 | 2.0 | 2.0 | 0.8 |
| Total Non-Current Assets | 547.6 | 430.5 | 439.3 | 418.4 | 1,090.4 | 383.4 | 365.2 | 118.4 | 100.0 | 13.5 |
| Total Assets | 2,013.7 | 1,485.6 | 1,786.4 | 1,610.0 | 2,204.5 | 2,271.8 | 962.5 | 587.4 | 342.9 | 116.6 |
| Current Liabilities | ||||||||||
| Account Payables | 54.4 | 38.6 | 51.7 | 68.9 | 38.5 | 7.3 | 16.2 | 10.6 | 5.0 | 3.2 |
| Short-Term Debt | 0 | 29.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 50.8 | 35.5 | 18.0 | 17.4 | 11.3 | 8.6 | 12.3 | 16.1 | 3.1 | 1.9 |
| Other Current Liabilities | 197.5 | 39.1 | 72.7 | 55.8 | 120.5 | 28.3 | 18.6 | 13.0 | 4.9 | 7.3 |
| Total Current Liabilities | 302.7 | 225.6 | 205.9 | 193.2 | 194.7 | 66.8 | 72.7 | 46.9 | 19.6 | 14.3 |
| Non-Current Liabilities | ||||||||||
| Long-Term Debt | 1,682.5 | 1,142.5 | 1,140.0 | 1,137.4 | 1,134.8 | 806.3 | 0 | 0 | 0 | 16.5 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 127.8 | 92.8 | 96.0 | 9.2 | 3.9 | 1.5 | 8.6 | 15.5 | 14.2 | 5.7 |
| Total Non-Current Liabilities | 1,810.2 | 1,399.7 | 1,421.8 | 1,356.6 | 1,364.8 | 849.4 | 41.8 | 15.5 | 14.7 | 22.6 |
| Total Liabilities | 2,113.0 | 1,625.3 | 1,627.7 | 1,549.8 | 1,559.5 | 916.2 | 114.5 | 62.5 | 34.3 | 36.9 |
| Stockholders' Equity | ||||||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0 | 0 |
| Retained Earnings | (2,994.5) | (2,578.2) | (2,141.9) | (1,662.4) | (1,007.8) | (606.6) | (352.8) | (280.8) | (195.7) | (107.6) |
| Accumulated Other Comprehensive Income | (4.9) | (5.2) | (3.7) | (19.5) | (4.8) | 2.7 | 1.1 | (0.1) | (0.5) | (0.1) |
| Total Stockholders' Equity | (99.3) | (139.6) | 158.7 | 60.2 | 645.0 | 1,298.5 | 798.4 | 483.2 | 308.6 | 79.7 |
| Total Liabilities & Equity | 2,013.7 | 1,485.6 | 1,786.4 | 1,610.0 | 2,204.5 | 2,271.8 | 962.5 | 587.4 | 342.9 | 116.6 |
| Debt Metrics | ||||||||||
| Total Debt | 1,682.5 | 1,336.1 | 1,353.8 | 1,369.3 | 1,373.7 | 854.5 | 40.4 | 0 | 0.7 | 17.0 |
| Net Debt | 1,304.3 | 810.5 | 220.2 | 1,227.6 | 881.5 | 21.5 | (102.8) | (140.5) | (71.6) | (16.6) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Net Income | (416.3) | (436.4) | (479.4) | (654.6) | (384.8) | (246.3) | (67.9) | (84.3) | (83.2) | (46.1) |
| Depreciation & Amortization | 39.7 | 42.4 | 42.9 | 36.0 | 22.3 | 16.1 | 11.4 | 7.1 | 5.2 | 3.7 |
| Stock-Based Compensation | 166.2 | 140.4 | 90.8 | 94.7 | 151.4 | 144.1 | 17.0 | 6.9 | 3.7 | 2.0 |
| Change in Working Capital | 9.8 | (60.9) | 53.8 | 61.6 | (40.5) | (47.7) | (8.3) | (1.1) | (5.0) | 2.5 |
| Other Non-Cash Items | 15.8 | 74.6 | (33.0) | 152.9 | 42.5 | 29.8 | 2.3 | (0.8) | 7.1 | 1.3 |
| Operating Cash Flow | (184.8) | (239.9) | (325.0) | (309.5) | (209.0) | (103.9) | (47.1) | (72.2) | (72.2) | (36.7) |
| Investing Activities | ||||||||||
| Capital Expenditure | (48.3) | (35.1) | (20.5) | (77.5) | (75.0) | (54.1) | (21.3) | (20.2) | (9.0) | (1.8) |
| Acquisitions | (59.0) | 0 | 0 | 0 | 0 | 0 | (7.3) | 0 | 0 | 0 |
| Purchases of Investments | (827.2) | (314.8) | (635.5) | (327.7) | (940.2) | (1,125.6) | (614.3) | (287.4) | (236.8) | (341.4) |
| Sales/Maturities of Investments | 307.3 | 88.6 | 1,496.2 | 555 | 952.1 | 562.5 | 325.3 | 154.6 | 75.4 | 369.4 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 | (17.9) | (2.6) | 0 | (2.3) | 0 |
| Investing Cash Flow | (627.2) | (261.3) | 840.2 | 149.8 | (63.2) | (617.1) | (317.6) | (153.0) | (170.4) | 26.2 |
| Financing Activities | ||||||||||
| Net Debt Issuance | 0 | 0 | 0 | (0.1) | (0.1) | 1,132.6 | (0.4) | (0.4) | (26.1) | (0.4) |
| Stock Repurchased | 13.6 | 0 | 0 | 0 | 0 | 0 | 0 | (0.2) | (7.2) | (0.1) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 569.7 | (15.8) | (15.7) | (189.0) | (66.7) | (78.0) | 17.3 | 39.8 | 0.8 | 0.3 |
| Financing Cash Flow | 671.1 | (1.0) | 477.4 | (189.1) | (66.8) | 1,410.3 | 367.3 | 293.2 | 281.7 | 39.8 |
| Cash Position | ||||||||||
| Net Change in Cash | (140.3) | (503.9) | 991.7 | (350.3) | (340.7) | 689.7 | 2.7 | 67.9 | 39.0 | 29.3 |
| Cash at Beginning | 629.8 | 1,133.7 | 141.9 | 492.3 | 833.0 | 143.2 | 140.5 | 72.6 | 33.6 | 4.3 |
| Cash at End | 489.4 | 629.8 | 1,133.7 | 141.9 | 492.3 | 833.0 | 143.2 | 140.5 | 72.6 | 33.6 |
| Free Cash Flow | (233.1) | (274.9) | (345.5) | (386.9) | (284.1) | (158.0) | (68.4) | (92.4) | (81.2) | (38.5) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 982.0 | 739.0 | 563.9 | 449.5 | 373.7 | 286.7 | 214.4 | 90.6 | 49.8 | 25.2 |
| Gross Profit | 633.0 | 449.2 | 336.9 | 293.2 | 250.7 | 194.2 | 143.7 | 47.4 | 18.2 | 3.1 |
| Operating Income | (436.3) | (443.6) | (564.7) | (544.4) | (411.0) | (254.9) | (82.4) | (92.9) | (76.6) | (43.8) |
| Net Income | (416.3) | (436.4) | (479.4) | (654.6) | (405.7) | (253.8) | (75.7) | (85.1) | (83.2) | (46.1) |
| EPS (Diluted) | -3.32 | -3.56 | -4.28 | -6.41 | -3.80 | -2.53 | -0.75 | -1.00 | -1.18 | -3.49 |
| Balance Sheet | ||||||||||
| Cash & Equivalents | 378.2 | 525.5 | 1,133.5 | 141.6 | 492.2 | 833.0 | 143.2 | 140.5 | 72.3 | 33.6 |
| Total Assets | 2,013.7 | 1,485.6 | 1,786.4 | 1,610.0 | 2,204.5 | 2,271.8 | 962.5 | 587.4 | 342.9 | 116.6 |
| Total Debt | 1,682.5 | 1,336.1 | 1,353.8 | 1,369.3 | 1,373.7 | 854.5 | 40.4 | 0 | 0.7 | 17.0 |
| Stockholders' Equity | (99.3) | (139.6) | 158.7 | 60.2 | 645.0 | 1,298.5 | 798.4 | 483.2 | 308.6 | 79.7 |
| Cash Flow | ||||||||||
| Operating Cash Flow | (184.8) | (239.9) | (325.0) | (309.5) | (209.0) | (103.9) | (47.1) | (72.2) | (72.2) | (36.7) |
| Capital Expenditure | (48.3) | (35.1) | (20.5) | (77.5) | (75.0) | (54.1) | (21.3) | (20.2) | (9.0) | (1.8) |
| Free Cash Flow | (233.1) | (274.9) | (345.5) | (386.9) | (284.1) | (158.0) | (68.4) | (92.4) | (81.2) | (38.5) |